Glucagon-like peptide-1 (GLP-1) receptor agonists have demonstrated significant clinical benefits for weight reduction, with studies showing average weight losses between 15 and 22 percent over six months of treatment
If you encounter any adverse reactions, discontinue use and consult a healthcare professional
HCPCS (2026) AHA Coding Clinic (Recent Guidance) The following AHA Coding Clinic advisories are relevant to DVT coding and should be referenced during audits and provider education: Superficial femoral vein deep vein: Coding Clinic has affirmed that despite its name, the superficial femoral vein is anatomically a deep vein and should be coded as DVT of the femoral vein (I82.41x), not as superficial thrombophlebitis
Novo Nordisks success is a testament to the transformative impact GLP-1 drugs are having on health, food consumption, and overall market dynamics
This case underscores the necessity of a coordinated effort among dermatologists, endocrinologists, and rheumatologists for effective AF treatment, illustrating the critical role of timely diagnosis and comprehensive care in managing this rare and challenging condition